Showing results (651-660 of 660) with videos related to
Sort By:
Pageof 66
You have reached the last page of results.This site can display upto 660 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2015
FDA approval: idelalisib monotherapy for the treatment of patients with follicular lymphoma and small lymphocytic lymphomaBarry W Miller, Donna Przepiorka, R Angelo de Claro, et al.Journal of Alzheimer'S Disease : JAD|September 1, 2025
Visual Cognitive Assessment Test correlates with brain amyloid status in Alzheimer's disease-related mild cognitive impairmentFeng-Juan Su, Yu-Cheng Li, Xin-Chong Shi, et al.Advanced Materials (Deerfield Beach, Fla.)|May 20, 2025
Hydrogel-Mediated Preservation of Live Tumor Explants for Drug Development in Peritoneal MetastasesKenny Zhuoran Wu, Rockie Haiyao Ding, Zixuan Zhao, et al.Translational Lung Cancer Research|January 13, 2023
Alectinib as first-line treatment for advanced ALK-positive non-small cell lung cancer in the real-world setting: preliminary analysis in a Chinese cohortZihua Zou, Yangchun Gu, Li Liang, et al.Neurotoxicology|July 2, 2008
Neurodevelopmental effects of maternal nutritional status and exposure to methylmercury from eating fish during pregnancyPhilip W Davidson, J J Strain, Gary J Myers, et al.Neurotoxicology|July 2, 2008
Associations of maternal long-chain polyunsaturated fatty acids, methyl mercury, and infant development in the Seychelles Child Development Nutrition StudyJ J Strain, Philip W Davidson, Maxine P Bonham, et al.Biomaterials|January 21, 2024
Bioengineered hydrogels enhance ex vivo preservation of patient-derived tumor explants for drug evaluationChristabella Adine, Kanishka Fernando, Nicholas Ching Wei Ho, et al.Cell Reports. Medicine|June 19, 2024
Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104)Chao Zhang, Yu-Xuan Sun, Ding-Cheng Yi, et al.Lung Cancer (Amsterdam, Netherlands)|June 28, 2020
A Phase III, randomized, double-blind, placebo-controlled, multicenter study of fruquintinib in Chinese patients with advanced nonsquamous non-small-cell lung cancer - The FALUCA studyShun Lu, Gongyan Chen, Yuping Sun, et al.Emerging Microbes & Infections|November 3, 2020
COVID-19 in children across three Asian cosmopolitan regionsGilbert T Chua, Xiaoli Xiong, Eun Hwa Choi, et al.Pageof 66